Legal, Regulatory Matters and Contingencies (Details)				1 Months Ended		12 Months Ended
	Jan. 14, 2020 USD ($)	May 22, 2019 USD ($)	May 10, 2019 company employee	Dec. 31, 2016 company	Nov. 30, 2016 item	Jun. 30, 2020 USD ($) Distributor lawsuit tranche product	Aug. 15, 2019 item	Jun. 30, 2018 item	Oct. 31, 2017 product	Oct. 06, 2017 product
Legal, Regulatory Matters and Contingencies
Settlement payment						$ 9,400,000
Reimbursement of overpayment						$ 8,100,000
State Attorneys General Inquiry into The Generic Pharmaceutical Industry
Legal, Regulatory Matters and Contingencies
Number of manufacturers and distributors | company			33	6
Number of drugs | product									13
Number of officers | employee			1
State Attorneys General Inquiry into The Generic Pharmaceutical Industry | Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs | product									1
Government Pricing
Legal, Regulatory Matters and Contingencies
Settlement payment		$ 9,400,000
Reimbursement of overpayment		$ 8,100,000
Private Antitrust and Consumer Protection Litigation
Legal, Regulatory Matters and Contingencies
Number of manufacturers and distributors | Distributor						30
Number of drugs						18	135			6
Number of Tranches | tranche						3
Private Antitrust and Consumer Protection Litigation | Minimum
Legal, Regulatory Matters and Contingencies
Number of lawsuits | lawsuit						100
End Payer Plaintiffs
Legal, Regulatory Matters and Contingencies
Number of drugs | item								14
Indirect Reseller Plaintiffs
Legal, Regulatory Matters and Contingencies
Number of drugs | item								15
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers | item					2
Litigation settlement amount payable to other party	$ 600,000